10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $716,678 | -26.1% | 17,374 | +0.0% | 0.02% | -22.6% |
| Q2 2023 | $969,941 | +0.0% | 17,370 | -0.1% | 0.03% | -6.1% |
| Q1 2023 | $969,574 | +30.5% | 17,379 | -14.8% | 0.03% | +3.1% |
| Q4 2022 | $742,975 | +29.0% | 20,389 | +0.8% | 0.03% | +18.5% |
| Q3 2022 | $576,000 | -36.9% | 20,235 | +0.3% | 0.03% | -35.7% |
| Q2 2022 | $913,000 | -39.6% | 20,166 | -0.3% | 0.04% | -30.0% |
| Q1 2022 | $1,512,000 | +36.7% | 20,234 | +172.5% | 0.06% | +46.3% |
| Q4 2021 | $1,106,000 | +110500.0% | 7,424 | +74140.0% | 0.04% | – |
| Q3 2021 | $1,000 | -50.0% | 10 | -9.1% | 0.00% | – |
| Q2 2021 | $2,000 | -99.7% | 11 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $630,000 | +20900.0% | 3,480 | +19233.3% | 0.03% | – |
| Q4 2020 | $3,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |